BEAM-201

Beam Therapeutics starts dosing in phase 1/2 trial of BEAM-201 in relapsed, refractory T-ALL/T-LL
Benzinga
Tue, 09/5/23 - 11:28 am
Beam Therapeutics
clinical trials
CAR-T
BEAM-201
T-ALL
T-LL
Beam jumps back into off-the-shelf CAR-T race after FDA lifts clinical hold
Fierce Biotech
Fri, 12/2/22 - 11:03 am
Beam Therapeutics
FDA
CAR-T
clinical trials
BEAM-201